Aydın ÇİFCİ, Özlem EROL, Salih CESUR, Nurkan AKSOY, Üçler KISA

The comparison of pandemic H1N1 IgG levels between H1N1 influenza-vaccinated healthcare workers and unvaccinated healthcare workers

To compare pandemic H1N1 (pH1N1) IgG antibody levels between healthcare workers who were vaccinated with the pH1N1 influenza vaccine and the unvaccinated healthcare workers who were selected as the control group. Materials and methods: A total of 68 healthcare workers were included in this study. Of those, 53 were adults vaccinated with the H1N1 influenza vaccine and 15 were unvaccinated. Serum samples were parsed and stored at -40 °C until they were examined. Results: Of the total 53 vaccinated healthcare workers, 16 (30.1%) were positive for IgG antibodies (titer > 11), 17 (32.0%) were negative for IgG antibodies (titer < 9), and 20 (37.7%) were borderline (titer: 9-11). Of the 15 unvaccinated healthcare workers, 1 (6.6%) was positive for IgG antibodies, 11 (73.3%) were negative for IgG antibodies, and the remaining 3 (20.0%) had borderline values (P = 0.014, P < 0.05). In both groups, there was no statistically significant difference between IgG-negative, IgG-positive, and borderline subjects in terms of age or sex. Conclusion: The IgG antibody level was higher in the vaccinated healthcare workers than among the unvaccinated healthcare workers.

Anahtar Kelimeler:

H1N1 vaccination, healthcare workers, H1N1 IgG antibody level

The comparison of pandemic H1N1 IgG levels between H1N1 influenza-vaccinated healthcare workers and unvaccinated healthcare workers

Keywords:

H1N1 vaccination, healthcare workers, H1N1 IgG antibody level,

PDF

___

Aktaş F. H1N1 Vaccine: To vaccinate or not? ANKEM Derg 2010; 24: 201–205.
Wood JM. Developing vaccines against pandemic influenza. Philos Trans R Soc Lond B Biol Sci 2001; 356: 1953–1960.
Simpson CR, Ritchie LD, Robertson C, Sheikh A, McMenamin J. Effectiveness of H1N1 vaccine for the prevention of pandemic influenza in Scotland, UK: a retrospective observational cohort study. Lancet Infect Dis 2012; 12: 696–702.
Noah C, Mohrmann G, Beckmann G, Sahly H, Stellbrink HJ. Impaired antibody response to pandemic H1N1 influenza vaccination in HIV-positive patients. In: 21st European Congress of Clinical Microbiology and Infectious Diseases. Milan, Italy; 7–10 May 2011; abstract number P2190.
Dikow R, Eckerle I, Ksoll-Rudek D, Hampel H, Schwenger V, Zeier M, Schnitzler P, Sommerer C. Immunogenicity and efficacy in hemodialysis patients of an AS03(A)- adjuvanted vaccine for 2009 pandemic influenza A (H1N1): a nonrandomized trial. Am J Kidney Dis 2011; 57: 716–723.
Lagler H, Grabmeier-Pfistershammer K, Touzeau-Römer V, Tobudic S, Ramharter M, Wenisch J, Gualdoni GA, Redlberger- Fritz M, Popow-Kraupp T, Rieger A et al. Immunogenicity and tolerability after two doses of non-adjuvanted, whole- virion pandemic influenza A (H1N1) vaccine in HIV-infected individuals. PLoS One 2012; 7: e36773.
Temiz G, Kasifoglu N, Kiris A, Ozturk S, Sahin G, Yalçın AU, Us T. Immune response after a single vaccination against 2009 influenza A H1N1 in hemodialysis patients. Ren Fail 2010; 32: 716–720.
Meyer S, Adam M, Schweiger B, Ilchmann C, Eulenburg C, Sattinger E, Runte H, Schlüter M, Deuse T, Reichenspurner H et al. Antibody response after a single dose of an AS03- adjuvanted split-virion influenza A (H1N1) vaccine in heart transplant recipients. Transplantation 2011; 91: 1031–1035.
Sayan M, Genç S, Yüce A, Uçan ES, Yuluğ N. ELISA for monitoring seroconversion in individuals vaccinated with influenza virus vaccine. Turk J Infection 2005; 19: 25–29.
Sun Y, Bian C, Xu K, Hu W, Wang T, Cui J, Wu H, Ling Z, Ji Y, Lin G et al. Immune protection induced on day 10 following administration of the 2009 A / H1N1 pandemic influenza vaccine. PLoS One 2010; 5: e14270.